E. Bourstyn

1.4k total citations
30 papers, 1.1k citations indexed

About

E. Bourstyn is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, E. Bourstyn has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 16 papers in Cancer Research and 12 papers in Pathology and Forensic Medicine. Recurrent topics in E. Bourstyn's work include Breast Cancer Treatment Studies (11 papers), Breast Lesions and Carcinomas (9 papers) and Cancer Treatment and Pharmacology (6 papers). E. Bourstyn is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Breast Lesions and Carcinomas (9 papers) and Cancer Treatment and Pharmacology (6 papers). E. Bourstyn collaborates with scholars based in France, Sweden and Japan. E. Bourstyn's co-authors include Anne Vincent‐Salomon, Jean-Marc Extra, Roman Rouzier, Marie-Christine Falcou, Bernard Asselain, Philippe Vielh, Jerzy Klijanienko, Marc Espié, P Pouillart and Alain Fourquet and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and British Journal of Cancer.

In The Last Decade

E. Bourstyn

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Bourstyn France 12 637 503 358 246 228 30 1.1k
Nurten Gündüz United States 12 692 1.1× 760 1.5× 259 0.7× 312 1.3× 216 0.9× 14 1.4k
Masataka Yoshimoto Japan 26 734 1.2× 810 1.6× 518 1.4× 236 1.0× 630 2.8× 84 1.8k
Takaomi Suzuma Japan 17 256 0.4× 306 0.6× 160 0.4× 164 0.7× 358 1.6× 52 885
Mireille H.J. Snel Netherlands 13 383 0.6× 545 1.1× 307 0.9× 125 0.5× 348 1.5× 18 994
Paulo Fidalgo Portugal 19 380 0.6× 778 1.5× 1.1k 3.0× 374 1.5× 422 1.9× 45 1.6k
R. Ghisini Italy 18 944 1.5× 1.0k 2.0× 323 0.9× 86 0.3× 280 1.2× 34 1.4k
E. Magherini France 12 409 0.6× 788 1.6× 145 0.4× 107 0.4× 154 0.7× 24 1.0k
Anna Cardillo Italy 17 613 1.0× 734 1.5× 211 0.6× 88 0.4× 252 1.1× 29 1.1k
Esko A. Kautto United States 7 581 0.9× 702 1.4× 424 1.2× 173 0.7× 475 2.1× 11 1.4k
M Galea United Kingdom 13 800 1.3× 619 1.2× 599 1.7× 180 0.7× 234 1.0× 20 1.3k

Countries citing papers authored by E. Bourstyn

Since Specialization
Citations

This map shows the geographic impact of E. Bourstyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Bourstyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Bourstyn more than expected).

Fields of papers citing papers by E. Bourstyn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Bourstyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Bourstyn. The network helps show where E. Bourstyn may publish in the future.

Co-authorship network of co-authors of E. Bourstyn

This figure shows the co-authorship network connecting the top 25 collaborators of E. Bourstyn. A scholar is included among the top collaborators of E. Bourstyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Bourstyn. E. Bourstyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guillerm, S., E. Bourstyn, L. Quéro, et al.. (2021). Intraoperative Radiotherapy for Breast Cancer in Elderly Women. Clinical Breast Cancer. 22(1). e109–e113. 4 indexed citations
2.
Campedel, Luca, Paul Blanc‐Durand, Jacqueline Lehmann‐Che, et al.. (2020). Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC. Cancers. 12(9). 2657–2657. 6 indexed citations
3.
Bécourt, Stéphanie, Odile Cohen‐Haguenauer, C. Cuvier, et al.. (2018). Comparison of clinicopathological (CP) features and outcome of breast cancers (BC) in BRCA-mutation carriers patients, with a family history without BRCA-mutation and with sporadic disease.. Journal of Clinical Oncology. 36(15_suppl). e13522–e13522. 4 indexed citations
4.
Quéro, L., S. Guillerm, Sophie Michaud, et al.. (2016). 10-Year follow-up of 621 patients treated using high-dose rate brachytherapy as ambulatory boost technique in conservative breast cancer treatment. Radiotherapy and Oncology. 122(1). 11–16. 11 indexed citations
5.
Lehmann‐Che, Jacqueline, Anne‐Sophie Hamy, Raphaël Porcher, et al.. (2013). Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15. Breast Cancer Research. 15(3). R37–R37. 79 indexed citations
6.
Bertheau, Philippe, Jacqueline Lehmann‐Che, Mariana Varna, et al.. (2013). p53 in breast cancer subtypes and new insights into response to chemotherapy. The Breast. 22. S27–S29. 151 indexed citations
7.
Lehmann‐Che, Jacqueline, E Turpin, Martine Antoine, et al.. (2011). Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches. British Journal of Cancer. 104(11). 1739–1746. 43 indexed citations
8.
9.
Hindié, Elif, David Groheux, E. Bourstyn, et al.. (2009). La technique du ganglion sentinelle dans le cancer du sein: quelques considérations récentes. Bulletin du Cancer. 96(6). 713–725. 14 indexed citations
10.
Espié, Marc, et al.. (2006). Cancer lobulaire infiltrant du sein : particularités diagnostiques et évolutives. Gynécologie Obstétrique & Fertilité. 34(1). 3–7. 4 indexed citations
11.
Cuvier, C., et al.. (2005). Cancer lobulaire in situ du sein. Particularités diagnostiques et évolutives. Gynécologie Obstétrique & Fertilité. 33(12). 964–969.
12.
Rouzier, Roman, Jean-Marc Extra, Jerzy Klijanienko, et al.. (2002). Incidence and Prognostic Significance of Complete Axillary Downstaging After Primary Chemotherapy in Breast Cancer Patients With T1 to T3 Tumors and Cytologically Proven Axillary Metastatic Lymph Nodes. Journal of Clinical Oncology. 20(5). 1304–1310. 265 indexed citations
13.
14.
Pierga, J-Y, E. Bourstyn, Claude Nos, et al.. (1999). Detection of circulating MUC1-positive cells in breast cancer. Breast Cancer Research and Treatment. 57(1). 120. 2 indexed citations
15.
Degeorges, Armelle, Anne de Roquancourt, Jean Marc Extra, et al.. (1998). Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?. Breast Cancer Research and Treatment. 47(1). 47–55. 34 indexed citations
16.
Faille, A, Patricia de Crémoux, J.M. Extra, et al.. (1994). p53 mutations and overexpression in locally advanced breast cancers. British Journal of Cancer. 69(6). 1145–1150. 61 indexed citations
17.
Culine, Stéphane, J.M. Extra, E. Bourstyn, et al.. (1993). [Promising results of bimonthly chemotherapy with high dose cyclophosphamide and epirubicin in induction treatment of inflammatory cancer of the breast].. PubMed. 80(11). 994–1000. 4 indexed citations
18.
Brice, Pauline, E. Bourstyn, M F D'Agay, et al.. (1991). Surgical restaging of advanced Hodgkin's disease after first line chemotherapy. European Journal Of Haematology. 46(5). 306–311. 2 indexed citations
19.
Belghiti, Jacques, et al.. (1987). Anorexia in oesophageal carcinoma.. PubMed. 13(5). 405–7. 3 indexed citations
20.
Belghiti, Jacques, et al.. (1983). Surgical implications of malnutrition and immunodeficiency in patients with carcinoma of the oesophagus. British journal of surgery. 70(6). 339–341. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nurten Gündüz Breakdown of academic impact, for papers by Masataka Yoshimoto Breakdown of academic impact, for papers by Takaomi Suzuma Breakdown of academic impact, for papers by Mireille H.J. Snel Breakdown of academic impact, for papers by Paulo Fidalgo Breakdown of academic impact, for papers by R. Ghisini Breakdown of academic impact, for papers by E. Magherini Breakdown of academic impact, for papers by Anna Cardillo Breakdown of academic impact, for papers by Esko A. Kautto Breakdown of academic impact, for papers by M Galea
Rankless by CCL
2026